NHSN AU & AR SDS Validation DASON has passed BOTH AU and AR Synthetic Data Set (SDS) validation through NHS… 2026 DICON-DASON Symposium Save the Date for the 2026 DICON-DASON Symposium: November 20, 2026 DASON Digest Podcast Check out the new audio offering from the DASON Team! Program Services Learn more about DASON program services NHSN AU & AR SDS Validation 2026 DICON-DASON Symposium DASON Digest Podcast Program Services Previous Next DASON’s primary goals are threefold: 1) to improve quality of patient care, 2) to enhance patient safety, and 3) to promote judicious antimicrobial use for patients treated in community hospitals Interested in Joining DASON Learn more Useful Links Learn More Current Members Request DASON Access Learn More News Comprehensive Review of Candidozyma (Candida) auris Management: Insights From the Society of Infectious Diseases Pharmacists March 12, 2026 Using Encounter-Level Data for Risk-Adjustment of Antimicrobial Use Comparisons: Feasibility and Variable Selection December 15, 2025 Targeted antimicrobial use admission provides an actionable denominator for evaluating inpatient length of therapy September 29, 2025 View All >
Comprehensive Review of Candidozyma (Candida) auris Management: Insights From the Society of Infectious Diseases Pharmacists March 12, 2026
Using Encounter-Level Data for Risk-Adjustment of Antimicrobial Use Comparisons: Feasibility and Variable Selection December 15, 2025
Targeted antimicrobial use admission provides an actionable denominator for evaluating inpatient length of therapy September 29, 2025
